Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years
- 1 September 2005
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 95 (3) , 254-258
- https://doi.org/10.1016/s1081-1206(10)61222-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Efficacy and safety of sublingual immunotherapyAnnals of Allergy, Asthma & Immunology, 2004
- Immunomodulation during sublingual therapy in allergic childrenPediatric Allergy and Immunology, 2003
- Sublingual immunotherapy for allergic rhinitisPublished by Wiley ,2003
- Long‐lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10‐year prospective studyClinical and Experimental Allergy, 2003
- Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implicationsAllergy, 2001
- Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in childrenAnnals of Allergy, Asthma & Immunology, 2000
- Clinical and immunologic effects of long‐term sublingual immunotherapy in asthmatic children sensitized to mites:a double‐blind, placebo‐controlled studyAllergy, 2000
- House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled studyAllergy, 2000
- Post‐marketing surveillance study on the safety of sublingual immunotherapy in pediatric patientsAllergy, 1999
- Systemic reactions to specific immunotherapy in children with respiratory allergy: a prospective studyPediatric Allergy and Immunology, 1995